Hepatocyte growth factor
CA 1300010 C · Owner: Mitsubishi Chemical Industries Limited · Inventors: Nakayama, Hiroyuki; Tsubouchi, Hirohito; Hashimoto, Shuji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
17 -, ABSTRACT:, A hepatocyte growth factor comprising a proteinous substance derived from human blood and showing the following physicochemical properties and physiologic activity: i) its molecular weight is estimated to be approximately 76,000 to 92,000 by SDS-PAGE analysis (under non-reductive condition); ii) it possesses HGF activity;, iii) the HGF activity is inactivated by heat treatment for 10 minutes at 80°C;, iv) the HGF activity may be lost by digestion with trypsin or with chymotrypsin; and v) it has a high affinity for heparin.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 5, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 5, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.